Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 487 across all filing types
Latest filing 2025-11-25 Major Shareholding Noti…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Change in substantial holding 3 pages 935.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 filed under the Corporations Act 2001 Section 671B, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and relevant interests of a substantial shareholder in a company, including dates, share quantities, and nature of changes. This form is a regulatory filing used to notify the market and regulators about changes in substantial shareholdings. It is not a financial report, earnings release, or management discussion, nor is it an announcement of a meeting or voting results. It is a specific notification about shareholding changes, which corresponds to the category 'Major Shareholding Notification' (MRQ). The document length is substantial and contains detailed data, confirming it is the actual notice, not just an announcement of a report. Therefore, the correct classification is MRQ with high confidence.
2025-11-25 English
OSX partners DKSH for dental products in Malaysia 5 pages 481.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 25 November 2025 about Osteopore Limited entering a 5-year partnership with DKSH Malaysia for distribution of dental products. It focuses on commercial terms, market strategy, and partnership details. There are no financial statements, regulatory certifications, voting results, or management changes. The content is a corporate announcement about a business partnership and distribution agreement, not a financial report, earnings release, or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. The document is a typical corporate announcement about a commercial partnership, which aligns best with the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2025-11-24 English
Further Drawdown of T1 of the Redeemable Convertible Notes 3 pages 263.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 25 November 2025 regarding a further drawdown of Tranche 1 of redeemable convertible notes by Osteopore Limited. It details subscription agreements, amounts raised, and use of funds. The content focuses on financing activities, specifically the issuance and subscription of convertible notes, which is a capital raising event. The document is about an update on financing and capital structure changes rather than a full financial report or earnings release. It is not a report publication announcement or a regulatory filing certification. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is about 5407 characters, which is sufficient for a substantive announcement rather than a brief notice.
2025-11-24 English
Cleansing Notice - Convertible Notes 22 pages 627.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 25 November 2025 regarding a Cleansing Notice for the issue of a subsequent tranche of convertible notes by Osteopore Limited. It details the terms of the convertible notes, the effect on the company's capital structure, pro forma financial position, and rights attaching to shares issued upon conversion. The document is a regulatory announcement about a capital raising and convertible note issuance, not a full financial report or earnings release. It does not contain comprehensive financial statements or management discussion but focuses on the financing transaction and compliance with disclosure laws. Therefore, it fits best under Capital/Financing Update (CAP). The document length (15,000 characters) and detailed financial impact analysis support this classification with high confidence.
2025-11-24 English
Notification regarding unquoted securities - OSX 6 pages 18.8KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of convertible notes by Osteopore Limited. It includes specifics such as the number of securities issued, issue price, purpose (to raise additional working capital), and compliance with ASX listing rules. The content focuses on the announcement of new securities issued and related capital changes. This matches the definition of a 'Share Issue/Capital Change' filing, which covers announcements regarding new share issues or other capital changes. The document is not a full financial report, earnings release, or management discussion, but a formal notification of a capital event.
2025-11-24 English
Becoming a substantial holder 3 pages 909.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Advance Opportunities Fund I in Osteopore Limited, including voting power, relevant interests, registered holders, consideration paid, and associates. This form is a regulatory disclosure about changes in major shareholding levels, specifically notifying the market of a substantial holder crossing a threshold. It is not a financial report, earnings release, or management discussion. The content matches the definition of a Major Shareholding Notification (MRQ). The document length and detail confirm it is the actual notification, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2025-11-20 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.